Quick Answer
ROCKET PHARMACEUTICALS, INC. reported Net Income of -$223.12 million for fiscal year 2025.
ROCKET PHARMACEUTICALS, INC. Net Income — Annual History
| Fiscal Year | Net Income | YoY Change |
|---|---|---|
| 2025 | -$223.12M | +13.8% |
| 2024 | -$258.75M | -5.4% |
| 2023 | -$245.59M | -10.7% |
| 2022 | -$221.86M | -31.2% |
| 2021 | -$169.07M | -21.0% |
| 2020 | -$139.70M | -80.8% |
| 2019 | -$77.27M | -3.7% |
| 2018 | -$74.52M | -280.6% |
| 2017 | -$19.58M | -158.5% |
| 2016 | -$7.57M | +88.9% |
| 2015 | -$67.98M | -613.3% |
| 2014 | -$9.53M | — |
Quarterly Net Income
| Quarter Ending | Net Income | YoY | QoQ |
|---|---|---|---|
| September 30, 2025 | -$50.33M | +24.6% | +27.0% |
| June 30, 2025 | -$68.92M | +1.0% | -12.4% |
| March 31, 2025 | -$61.33M | +1.2% | +8.1% |
| September 30, 2024 | -$66.72M | -7.8% | +4.2% |
| June 30, 2024 | -$69.65M | -6.0% | -12.2% |
| March 31, 2024 | -$62.05M | -6.4% | -0.3% |
| September 30, 2023 | -$61.90M | -7.2% | +5.8% |
| June 30, 2023 | -$65.70M | -20.8% | -12.6% |
- ROCKET PHARMACEUTICALS, INC. showed an increase of +13.8% in Net Income compared to the prior fiscal year.
- Over the 2014–2025 period, ROCKET PHARMACEUTICALS, INC.’s net income has declined by 2241.0% (from -$9.53 million to -$223.12 million).
- The most recent figure is from ROCKET PHARMACEUTICALS, INC.’s fiscal year 2025 report (Form 10-K), filed with the SEC on February 26, 2026.
- All figures are sourced from SEC EDGAR XBRL filings, last verified June 17, 2026.
Last verified: